Doxepin and imipramine but not fluoxetine reduce the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes

BMC Anesthesiology

Volumn 15, Issue 1, 2015, Pages

  Park, Hye Jin ^a   Baik, Hee Jung ^b   Kim, Dong Yeon ^b   Lee, Guie Yong ^b   Woo, Jae Hee ^b   Zuo, Zhiyi ^c   Chung, Rack Kyung ^b  

^a Dasom anesthesia and analgesia practice association   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXEPIN; EXCITATORY AMINO ACID TRANSPORTER 3; FLUOXETINE; GLUTAMIC ACID; IMIPRAMINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; ANTIDEPRESSANT AGENT; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; MEMBRANE CURRENT; NONHUMAN; OOCYTE; XENOPUS LAEVIS; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; METABOLISM; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXEPIN; EXCITATORY AMINO ACID TRANSPORTER 3; FEMALE; FLUOXETINE; GLUTAMIC ACID; IMIPRAMINE; OOCYTES; PROTEIN KINASE C; RATS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; XENOPUS LAEVIS;

EID: 84938589220     PISSN: None     EISSN: 14712253     Source Type: Journal    
DOI: 10.1186/s12871-015-0098-5     Document Type: Article

References (38)

1. Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1-105.
2. Kanai Y, Hediger MA. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature. 1992;360:467-71.
3. Kanai Y, Smith CP, Hediger MA. A new family of neurotransmitter transporters: the high-affinity glutamate transporters. FASEB J. 1993;7:1450-9.
4. Maragakis NJ, Rothstein JD. Glutamate transporters in neurologic disease. Arch Neurol. 2001;58:365-70.
5. Nieoullon A, Canolle B, Masmejean F, Guillet B, Pisano P, Lortet S. The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse? J Neurochem. 2006;98:1007-18.
6. Paul IA, Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci. 2003;1003:250-72.
7. Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry. 1999;46:1181-91.
8. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 2000;47:305-13.
9. Palucha A, Pilc A. The involvement of glutamate in the pathophysiology of depression. Drug News Perspect. 2005;18:262-8.
10. Chan HN, Fam J, Ng BY. Use of antidepressants in the treatment of chronic pain. Ann Acad Med Singapore. 2009;38:974-9.
11. Abdel-Salam OM, Nofal SM, El-Shenawy SM. Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat. Pharmacol Res. 2003;48:157-65.
12. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992;326:1250-6.
13. Pittaluga A, Raiteri L, Longordo F, Luccini E, Barbiero VS, Racagni G, et al. Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus. Neuropharmacology. 2007;53:27-36.
14. Reznikov LR, Grillo CA, Piroli GG, Pasumarthi RK, Reagan LP, Fadel J. Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment. Eur J Neurosci. 2007;25:3109-14.
15. Bouron A, Chatton JY. Acute application of the tricyclic antidepressant desipramine presynaptically stimulates the exocytosis of glutamate in the hippocampus. Neuroscience. 1999;90:729-36.
16. Baik HJ, Lee SA, Washington JM, Zuo ZY. Amitriptyline inhibits the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes. J Pharm Pharmacol. 2009;61:577-81.
17. Sanchez C, Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol. 1999;19:467-89.
18. Martinez-Turrillas R, Del Rio J, Frechilla D. Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugs. Biochem Biophys Res Commun. 2007;353:750-5.
19. Millan MJ. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review. Eur J Pharmacol. 2004;500:371-84.
20. Huang Y, Zuo Z. Isoflurane induces a protein kinase C alpha-dependent increase in cell-surface protein level and activity of glutamate transporter type 3. Mol Pharmacol. 2005;67:1522-33.
21. Do SH, Kamatchi GL, Washington JM, Zuo Z. Effects of volatile anesthetics on glutamate transporter, excitatory amino acid transporter type 3: the role of protein kinase C. Anesthesiology. 2002;96:1492-7.
22. Kim JH, Lim YJ, Ro YJ, Min SW, Kim CS, Do SH, et al. Effects of ethanol on the rat glutamate excitatory amino acid transporter type 3 expressed in Xenopus oocytes: role of protein kinase C and phosphatidylinositol 3-kinase. Alcohol Clin Exp Res. 2003;27:1548-53.
23. Woo JH, Han JI, Baik HJ, Lee H. Effects of clonidine on the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes. Korean J Anesthesiol. 2012;62:266-71.
24. Wille SM, Cooreman SG, Neels HM, Lambert WE. Relevant issues in the monitoring and the toxicology of antidepressants. Crit Rev Clin Lab Sci. 2008;45:25-89.
25. Leucht S, Steimer W, Kreuz S, Abraham D, Orsulak PJ, Kissling W. Doxepin plasma concentrations: is there really a therapeutic range? J Clin Psychopharmacol. 2001;21:432-9.
26. Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, et al. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry. 2004;56:640-50.
27. Sepkuty JP, Cohen AS, Eccles C, Rafiq A, Behar K, Ganel R, et al. A neuronal glutamate transporter contributes to neurotransmitter GABA synthesis and epilepsy. J Neurosci. 2002;22:6372-9.
28. Pita-Almenar JD, Collado MS, Colbert CM, Eskin A. Different mechanisms exist for the plasticity of glutamate reuptake during early long-term potentiation (LTP) and late LTP. J Neurosci. 2006;26:10461-1071.
29. Aoyama K, Suh SW, Hamby AM, Liu J, Chan WY, Chen Y, et al. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci. 2006;9:119-26.
30. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 1996;16:675-86.
31. Levenson J, Weeber E, Selcher JC, Kategaya LS, Sweatt JD, Eskin A. Long-term potentiation and contextual fear conditioning increase neuronal glutamate uptake. Nat Neurosci. 2002;5:155-61.
32. Andin J, Stenfors C, Ross SB, Marcusson J. Modulation of neuronal glutamate transporter rEAAC1 mRNA expression in rat brain by amitriptyline. Brain Res Mol Brain Res. 2004;126:74-7.
33. Sugawara M, Kato M, Kobayashi M, Iseki K, Miyazaki K. Mechanism of the inhibitory effect of imipramine on the Na + -dependent transport of L-glutamic acid in rat intestinal brush-border membrane. Biochim Biophys Acta. 1998;1370:252-8.
34. McCullumsmith RE, Meador-Woodruff JH. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology. 2002;26:368-75.
35. Goren MZ, Kucukibrahimoglu E, Berkman K, Terzioglu B. Fluoxetine partly exerts its actions through GABA: a neurochemical evidence. Neurochem Res. 2007;32:1559-65.
36. Ferrero AJ, Cereseto M, Reines A, Bonavita CD, Sifonios LL, Rubio MC, et al. Chronic treatment with fluoxetine decreases seizure threshold in naive but not in rats exposed to the learned helplessness paradigm: Correlation with the hippocampal glutamate release. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:678-86.
37. Uezato A, Meador-Woodruff JH, McCullumsmith RE. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia. Bipolar Disord. 2009;11:711-25.
38. Tordera RM, Pei Q, Sharp T. Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment. J Neurochem. 2005;94:875-83.